OWC Pharmaceutical Research Corp (OWCP)

[Farmer7]

Cream phase 1 safety study near complete and going into phase 2 efficacy 2019.

Sublingual tablet phase 1 safety study complete in early to mid 2019 and going into phase 2 efficacy in 2019.

Nasal spray phase 1 safety human study starting in 2019.

MM study moving forward using a Parenteral delivery system, study is designed for orphan drug.

Yes, OWCP needs to finish just one of these studies. But at the end of the day, OWCP truly does have a lot going starting in 2019 and beyond!

I watched Hirsch speak at the Wall Street Conference last year. He was a good speaker and I would assume he would be the speaker at the JP Morgan conference addressing all these studies to a healthcare crowd. Their work will be valued much more at that conference then the Wall Street Conference.

Happy Friday and best of luck all!